Articles related to NEUROLOGICAL DISORDERS

Manifest Technologies is spearheading the use of AI in developing targeted treatments for CNS disorders, aiming to refine patient selection in clinical trials and enhance therapeutic outcomes.

Understanding the genetic intricacies of cerebral cavernous malformations is pivotal in tailoring patient care, as these insights not only aid in accurate diagnosis but also open the door to innovative treatments aimed at mitigating the risk of neurological complications.

Physicians should be acutely aware of the heightened risk of neuroinvasive arboviral infections in patients treated with rituximab, necessitating a shift towards molecular diagnostic testing for timely and accurate detection.

Discover a compelling case of idiopathic intracranial hypertension linked to severe obesity, highlighting the critical importance of early diagnosis and the dual approach of medication and lifestyle changes in treatment.

Advanced biological aging, as measured by clinical biomarkers, increases one’s risk for dementia or stroke, despite adjustment for disease-specific risk factors. This finding underscores the potential of biological age as a predictor of neurological health.

Healthcare professionals should be aware of the potential for neurological side effects in patients receiving COVID-19 vaccines. With nearly one-third of vaccine recipients experiencing symptoms such as headaches, tremors, and insomnia, continued monitoring and research are crucial.